What is the turnover of eisai pharmaceutical company?

As of my last update in October 2023, Eisai Co., Ltd. reported a revenue of approximately ¥700 billion (around $6.4 billion) for the fiscal year ending March 2023. The company is known for its focus on neurology and oncology, with significant sales from products like the Alzheimer's treatment, Lecanemab. For the most current figures, it is advisable to check the latest financial reports or news releases from Eisai.